Cite

HARVARD Citation

    Covelli, M. et al. (n.d.). AB0561 Risk of HBV infection reactivation in patients with rheumatoid arthritis undergoing treatment with ANTI-CD20 (RITUXIMAB). Annals of the rheumatic diseases. p. 670. [Online]. 
  
Back to record